학술논문
Fixed-duration venetoclax-obinutuzumab for previously untreated patients with chronic lymphocytic leukemia: Follow-up of efficacy and safety results from the multicenter, open-label, randomized, phase III CLL14 trial.
Document Type
Journal
Author
Al-Sawaf, Othman; Zhang, Can; Tandon, Maneesh; Sinha, Arijit; Fink, Anna Maria; Robrecht, Sandra; Tausch, Eugen; Schary, William L.; Ritgen, Matthias; Wendtner, Clemens Martin; Kreuzer, Karl A.; Eichhorst, Barbara; Stilgenbauer, Stephan; Hallek, Michael J.; Fischer, Kirsten; CLL14 Study Investigators
Source
Subject
Language
English
ISSN
15277755